MwanzoLSTA • NASDAQ
add
Lisata Therapeutics Inc
Bei iliyotangulia
$ 2.48
Bei za siku
$ 2.36 - $ 2.50
Bei za mwaka
$ 1.87 - $ 4.20
Thamani ya kampuni katika soko
20.76M USD
Wastani wa hisa zilizouzwa
elfu 12.09
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.00M | — |
Matumizi ya uendeshaji wa biashara | 5.95M | -1.26% |
Mapato halisi | -4.61M | 14.07% |
Kiwango cha faida halisi | -461.00 | — |
Mapato kwa kila hisa | -0.55 | 16.67% |
EBITDA | -4.91M | 17.90% |
Asilimia ya kodi ya mapato | 0.00% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 31.24M | -38.17% |
Jumla ya mali | 35.00M | -36.00% |
Jumla ya dhima | 5.68M | -16.40% |
Jumla ya hisa | 29.32M | — |
hisa zilizosalia | 27.70M | — |
Uwiano wa bei na thamani | 0.70 | — |
Faida inayotokana na mali | -33.80% | — |
Faida inayotokana mtaji | -39.23% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -4.61M | 14.07% |
Pesa kutokana na shughuli | -4.53M | -11.28% |
Pesa kutokana na uwekezaji | 1.39M | 124.31% |
Pesa kutokana na ufadhili | elfu -96.00 | -500.00% |
Mabadiliko halisi ya pesa taslimu | -3.30M | 66.45% |
Mtiririko huru wa pesa | -2.95M | -25.90% |
Kuhusu
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Ilianzishwa
1980
Makao Makuu
Tovuti
Wafanyakazi
26
